Global Topical Scar Treatment Market Size, Share & Trends Analysis Report By End-use, By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks), By Product, By Regional Outlook and Forecast, 2023 - 2030
The Global Topical Scar Treatment Market size is expected to reach $28.9 billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.
Consumers in North America are often well-informed about skincare trends and are likely to seek solutions for scar reduction. Therefore, the North America region captured $5,287.0 million revenue in the market in 2022. Individuals in North America can browse and buy various skincare products, including topical scar treatments, through online retail.
Social media platforms, including Instagram, TikTok, and YouTube, provide a global stage for beauty trends and skincare routines. Influencers and beauty enthusiasts often share their skincare journeys, including scar management experiences and increasing visibility and awareness of topical scar treatments. Therefore, the market is expanding significantly due to the influence of social media and beauty trends.
Additionally, seniors often undergo surgical procedures for various health conditions, ranging from joint replacements to cardiac surgeries. Post-surgical scarring is common, creating a demand for scar management solutions, including topical treatments. Thus, because of the increasing number of senior citizens, the market is anticipated to increase significantly.
However, Individuals with lower disposable incomes may struggle to afford high-cost advanced formulations. This can reduce accessibility to effective scar treatments for population segments, impacting market penetration. Consumers are often sensitive to product prices, and high-cost formulations may discourage potential buyers. Thus, high cost can slow down the growth of the market.
The skincare industry, like many others, experienced disruptions in the supply chain due to lockdowns, restrictions on movement, and closure of manufacturing facilities. This impacted the availability of raw materials and the production of scar treatment products. Economic uncertainties and changes in consumer spending patterns affected consumers’ purchasing power, potentially impacting the sales of premium skincare products, including specialized scar treatments. Thus, the COVID-19 pandemic had a moderate effect on the market.
By End-use Analysis
On the basis of end-use, the market is divided into hospitals, clinics, and homecare. In 2022, the hospitals segment dominated the market with 42.6% revenue share. Hospitals frequently use topical scar treatments to manage and minimize scarring resulting from surgical procedures. Scar prevention and reduction are essential aspects of post-operative care.
By Scar Type Analysis
Based on scar type, the market is classified into atrophic scars, hypertrophic & keloid scars, contracture scars, and stretch marks. The hypertrophic & keloid scars segment acquired 26.5% revenue share in the market in 2022. Hypertrophic & keloid scars are often associated with itching and discomfort.
By Product Analysis
By product, the market is categorized into creams, gels, silicon sheets, and others. In 2022, the creams segment held 38.1% revenue share in the market. Creams are user-friendly and easy to apply, making them convenient for individuals seeking a hassle-free scar treatment option. This ease of application encourages regular use, which is crucial for the effectiveness of scar treatments.
By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired 27.1% revenue share in the market. Rising disposable income in certain countries within the Asia Pacific region allows consumers to spend more on skincare and cosmetic products, including topical scar treatments.
List of Key Companies Profiled
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
Global Topical Scar Treatment Market Report Segmentation
By End-use
By Scar Type
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
By Product
- Creams
- Gels
- Silicon Sheets
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA